We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Exit Notice

You are about to leave ClinicalTrials.gov and go to: To obtain contact information for a study center near you, click here. URL: https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B9991009&StudyName=A+Phase+3%2C+Multicenter%2C+Randomized%2C+Open-label+Study+Of+Avelumab+%28msb0010718c%29+Alone+Or+In+Combination+With+Pegylated+Liposomal+Doxorubicin+Versus+Pegylated+Liposomal+Doxorubicin+Alone+In+Patients+With+Platinum-resistant%2Frefractory+Ovarian+Cancer

Click on the link to continue or return to ClinicalTrials.gov Home